Page last updated: 2024-09-04

moxifloxacin and ml-3000

moxifloxacin has been researched along with ml-3000 in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(ml-3000)
Trials
(ml-3000)
Recent Studies (post-2010) (ml-3000)
3,1575521,690130956

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)ml-3000 (IC50)
Prostaglandin E synthaseHomo sapiens (human)6.14
Prostaglandin G/H synthase 1 Bos taurus (cattle)0.1925
Prostaglandin G/H synthase 2 Bos taurus (cattle)0.21
Prostaglandin G/H synthase 1Ovis aries (sheep)0.185
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)0.3017
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)3.6
Prostaglandin G/H synthase 1Homo sapiens (human)2.7425
Prostaglandin G/H synthase 2Homo sapiens (human)0.422
5-lipoxygenase Bos taurus (cattle)0.47

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Codd, R; Gotsbacher, MP; Roth, L1

Other Studies

1 other study(ies) available for moxifloxacin and ml-3000

ArticleYear
Immobilized Metal Affinity Chromatography as a Drug Discovery Platform for Metalloenzyme Inhibitors.
    Journal of medicinal chemistry, 2020, 10-22, Volume: 63, Issue:20

    Topics: Chromatography, Affinity; Coordination Complexes; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imino Acids; Metalloproteins; Metals, Heavy; Models, Molecular; Molecular Structure; Structure-Activity Relationship

2020